News

Deal Announcements

Aegerion Pharma Nets $15 Million In New Debt

Friday, March 23, 2007 6:30:00 AM PDT | VentureDeal Staff
BRIDGEWATER, NJ -- Aegerion Pharmaceuticals has received a $15 million debt facility from Hercules Technology Growth Capital (Nasdaq: HTGC).

Aegerion is a specialty pharmaceutical company focused on the development of therapeutics to treat cardiovascular and metabolic disease.

The company did not disclose how the proceeds would be used.  Previous financing included a $22.5 million series A round in June, 2006 from Advent International, Alta Partners, MVM Life Partners and Index Ventures.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1